Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma [Phase 4]
Phase 4 pharmacokinetic study of bortezomib conducted in Taiwanese patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of sorafenib and everolimus in relapsed or refractory lymphoma and multiple myeloma with results po…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment [Phase 3]
Phase 3 trial evaluating ondansetron for chronic nausea and vomiting in patients with advanced cancer not caused by cancer treatment; the st…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM [Phase 1]
Phase I trial evaluating the combination of bortezomib (Velcade) and pralatrexate in relapsed/refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating peripheral stem cell transplantation in adults with multiple myelo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment [Phase 1]
Phase 1 trial of the agent 506U78 in patients with hematologic cancers and kidney or liver impairment; the study has terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating donor stem cell transplantation for patients with relapsed hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer [NA]
This terminated clinical trial evaluated a conditioning regimen of fludarabine, cyclophosphamide, and total-body irradiation followed by cyc…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies [Phase 1]
Phase 1 safety study evaluating a natural killer (NK) cell line for hematologic cancers has completed, assessing its use against leukemia, l…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
This Phase II trial evaluated a regimen of Revlimid (lenalidomide) with oral cyclophosphamide and prednisone in newly diagnosed multiple mye…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Combination of Lenalidomide and Autologous Mature Dendritic Cells Pulsed With KRN7000 in Myeloma [Phase 1]
Phase 1 trial evaluating the combination of lenalidomide with autologous mature dendritic cells pulsed with KRN7000 in multiple myeloma; the…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT [Phase 2, Phase 3]
Clinical trial update on assessing molecular remission by ASO-qPCR after bortezomib-dexamethasone induction followed by autologous stem cell…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: A Safety Confirmation Study on Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Multiple Myeloma [Phase 3]
Phase 3 safety confirmation study of lenalidomide with dexamethasone in Japanese patients with previously treated multiple myeloma completed…
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Lenalidomide and High-Dose Melphalan [Phase 1, Phase 2]
Clinical trial update on lenalidomide with high-dose melphalan for patients with multiple myeloma undergoing stem cell transplantation. The …
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies [Phase 1]
Phase 1 trial evaluating a conditioning regimen of gemcitabine, busulfan, and melphalan with hematopoietic cell transplantation for advanced…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating bortezomib-based consolidation in multiple myeloma patients after stem cell transplantation has completed …
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating alisertib (MLN8237) in combination with bortezomib for relapsed or refractory multiple myeloma has com…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 clinical trial update evaluating bendamustine, bortezomib (Velcade), and prednisone (BVP) in newly diagnosed multiple myeloma. The s…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma [Phase 2]
Open-label Phase 2 trial of imetelstat in patients with previously treated multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Phase I Study of Sequential Cord Blood Transplants [Phase 1]
Phase I study of sequential cord blood transplants has completed enrollment for conditions including lymphoma, leukemia, multiple myeloma, a…
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating a four-drug combination of melphalan, prednisone, thalidomide, and defibrotide in relapsed m…
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: RMPT for Relapsed/Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating RMPT for relapsed/refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies [Phase 1]
Phase 1 study evaluating TG02 Citrate in patients with advanced hematologic malignancies has completed, including AML, ALL, blast crisis, MD…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
A Duke University registry study evaluating T-cell depleted allogeneic non-myeloablative stem cell transplantation for hematologic cancers h…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease [Phase 1]
This Phase 1 study evaluated the pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal d…